{"url_path":"/sec/kod/8-k/2026-06-04/item-5-07","section_key":"item-5-07","section_title":"Item 5.07 Submission of Matters to a Vote of Security Holders.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-04","source_url":"https://www.sec.gov/Archives/edgar/data/1468748/0001193125-26-257766-index.html","accession_number":"0001193125-26-257766","cik":"0001468748","ticker":"KOD","issuer_name":"Kodiak Sciences Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1468748/0001193125-26-257766-index.html","primary_entity_key":"0001468748","primary_entity_name":"Kodiak Sciences Inc."},"word_count":280,"has_tables":true,"body_markdown":"Item 5.07\n\nSubmission of Matters to a Vote of Security Holders.\n\nOn June 2, 2026, Kodiak Sciences Inc. (the “Company”) held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”). At the Annual Meeting, proxies representing 55,026,544 shares of the Company’s common stock, or 88.53% of the total shares entitled to vote, were present and voted on the following proposals, which are described in more detail in the Company’s definitive proxy statement filed with the United States Securities and Exchange Commission on April 22, 2026:\n\nProposal One – Election of Class II Directors.\n\nThe following nominees were each elected as a Class II director to serve until the 2029 annual meeting of stockholders or until his or her successor is duly elected and qualified.\n\n \n\nNominee\n\n  \nFor\n  \nWithheld\n  \nBroker Non-Votes\n\nCharles A. Bancroft\n\n  \n38,940,529\n  \n10,560,815\n  \n5,525,200\n\nBassil I. Dahiyat, Ph.D.\n\n  \n48,843,144\n  \n658,200\n  \n5,525,200\n\nTaiyin Yang, Ph.D.\n\n  \n49,192,610\n  \n308,734\n  \n5,525,200\n\nProposal Two – Advisory Approval of the Compensation of Named Executive Officers.\n\nThe compensation of the Company’s named executive officers was approved, on an advisory basis, by the stockholders.\n\n \n\nFor\n\n \n\nAgainst\n\n \n\nAbstain\n\n \n\nBroker Non-Votes\n\n49,157,143\n \n323,196\n \n21,005\n \n5,525,200\n\nProposal Three – Ratification of the Appointment of Independent Registered Public Accounting Firm.\n\nThe appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the Company’s fiscal year ending December 31, 2026 was ratified.\n\n \n\nFor\n\n \n\nAgainst\n\n \n\nAbstain\n\n \n\nBroker Non-Votes\n\n54,716,676\n \n52,962\n \n256,906\n \n—\n\n \n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n\n \n\n \nKODIAK SCIENCES INC.\n\nDate: June 4, 2026\n \n\n \nBy:\n \n\n/s/ Victor Perlroth\n\n \n\n \n\n \nVictor Perlroth, M.D.\n\n \n\n \n\n \nChief Executive Officer"}